Diet, urate, and Parkinson's disease risk in men - PubMed (original) (raw)
Diet, urate, and Parkinson's disease risk in men
Xiang Gao et al. Am J Epidemiol. 2008.
Abstract
The authors examined whether a diet that increases plasma urate level is also related to reduced risk of Parkinson's disease (PD). The study population comprised 47,406 men in the Health Professionals Follow-up Study. The potential effect of diet on plasma urate level was estimated by regressing plasma urate on intakes of selected foods and nutrients in a subsample of 1,387 men. Coefficients of this regression model were then used to calculate a dietary urate index for all cohort participants. Multivariate relative risks of PD were estimated by means of Cox proportional hazards models. After 14 years of follow-up (1986-2000), the authors documented 248 incident cases of PD. A higher dietary urate index was associated with a lower risk of PD (top quintile vs. bottom: relative risk = 0.47, p-trend = 0.0008), after adjustment for age, smoking, caffeine intake, and other potential confounders. This association remained strong and significant after further adjustment for each component of the index individually (p-trend < 0.02 for each). These data support urate as a potentially protective factor in PD and suggest that dietary changes expected to increase plasma urate level may contribute to lower risk of PD. These potential benefits, however, should be weighed against expected adverse effects on risk of gout and other chronic diseases.
Figures
FIGURE 1
Relative risk (RR) of Parkinson’s disease according to quintile (Q) of baseline dietary urate index in the Health Professionals Follow-up Study, 1986-2000. Results were adjusted for age (in months), smoking status (never smoker, past smoker, or current smoker of 1-14 cigarettes/day or ≥15 cigarettes/day), body mass index (weight (kg)/height (m)2; <23, 23-24.9, 25-26.9, 27-29.9, or ≥30), use of nonsteroidal antiinflammatory drugs (yes/no), use of diuretics (yes/no), physical activity (quintiles), caloric intake (kcal/day), and caffeine intake (quintiles). p for trend = 0.0008. Bars, 95% confidence interval.
Similar articles
- Plasma urate and risk of Parkinson's disease.
Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Weisskopf MG, et al. Am J Epidemiol. 2007 Sep 1;166(5):561-7. doi: 10.1093/aje/kwm127. Epub 2007 Jun 20. Am J Epidemiol. 2007. PMID: 17584757 Free PMC article. - Urate and the risk of Parkinson's disease in men and women.
Cortese M, Riise T, Engeland A, Ascherio A, Bjørnevik K. Cortese M, et al. Parkinsonism Relat Disord. 2018 Jul;52:76-82. doi: 10.1016/j.parkreldis.2018.03.026. Epub 2018 Mar 28. Parkinsonism Relat Disord. 2018. PMID: 29615298 - Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study.
Chen H, Mosley TH, Alonso A, Huang X. Chen H, et al. Am J Epidemiol. 2009 May 1;169(9):1064-9. doi: 10.1093/aje/kwp033. Epub 2009 Mar 18. Am J Epidemiol. 2009. PMID: 19299404 Free PMC article. - Urate as a marker of development and progression in Parkinson's disease.
Constantinescu R, Zetterberg H. Constantinescu R, et al. Drugs Today (Barc). 2011 May;47(5):369-80. doi: 10.1358/dot.2011.47.5.1591834. Drugs Today (Barc). 2011. PMID: 22013567 Review. - Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.
Cipriani S, Chen X, Schwarzschild MA. Cipriani S, et al. Biomark Med. 2010 Oct;4(5):701-12. doi: 10.2217/bmm.10.94. Biomark Med. 2010. PMID: 20945982 Free PMC article. Review.
Cited by
- Prospective study of statin use and risk of Parkinson disease.
Gao X, Simon KC, Schwarzschild MA, Ascherio A. Gao X, et al. Arch Neurol. 2012 Mar;69(3):380-4. doi: 10.1001/archneurol.2011.1060. Arch Neurol. 2012. PMID: 22410446 Free PMC article. - Alcohol drinking and risk of Parkinson's disease: a case-control study in Japan.
Fukushima W, Miyake Y, Tanaka K, Sasaki S, Kiyohara C, Tsuboi Y, Yamada T, Oeda T, Miki T, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M; Fukuoka Kinki Parkinson's Disease Study Group. Fukushima W, et al. BMC Neurol. 2010 Nov 5;10:111. doi: 10.1186/1471-2377-10-111. BMC Neurol. 2010. PMID: 21054827 Free PMC article. - Pathogenesis-targeted, disease-modifying therapies in Parkinson disease.
AlDakheel A, Kalia LV, Lang AE. AlDakheel A, et al. Neurotherapeutics. 2014 Jan;11(1):6-23. doi: 10.1007/s13311-013-0218-1. Neurotherapeutics. 2014. PMID: 24085420 Free PMC article. Review. - Midlife milk consumption and substantia nigra neuron density at death.
Abbott RD, Ross GW, Petrovitch H, Masaki KH, Launer LJ, Nelson JS, White LR, Tanner CM. Abbott RD, et al. Neurology. 2016 Feb 9;86(6):512-9. doi: 10.1212/WNL.0000000000002254. Epub 2015 Dec 9. Neurology. 2016. PMID: 26658906 Free PMC article. - Association of Serum Uric Acid Level with the Severity of Brain Injury and Patient's Outcome in Severe Traumatic Brain Injury.
Hatefi M, Dastjerdi MM, Ghiasi B, Rahmani A. Hatefi M, et al. J Clin Diagn Res. 2016 Dec;10(12):OC20-OC24. doi: 10.7860/JCDR/2016/21918.8993. Epub 2016 Dec 1. J Clin Diagn Res. 2016. PMID: 28208906 Free PMC article.
References
- Jenner P. Oxidative stress in Parkinson’s disease. Ann Neurol. 2003;53(suppl 3):S26–36. - PubMed
- de Lau LM, Koudstaal PJ, Hofman A, et al. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol. 2005;58:797–800. - PubMed
- Davis JS, Grandinetti A, Waslien CI, et al. Observations on serum uric acid and the risk of idiopathic Parkinson’s disease. Am J Epidemiol. 1996;144:480–4. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical